Pharmacovigilance – Products

Cyprotex announce the successful cross validation of the CellCiphr(TM) cytotoxicity panels. These panels detect toxicological markers in a range of cell models, HepG2, primary hepatocytes and cardiomyocytes.

Alvetex® is a material that provides an inert scaffold for cells to grow and form complex 3D cell structures in the laboratory.

CYTOOplates bring sensitivity and quantification to cell-based assays and screening.

This technology enables researchers and clinical pathologists to isolate, noninvasively, from fecal samples (0.5 g aliquots) viable host cells from humans and animals (both farm and companion animals and wildlife). Cell populations include functional epithelial cells, leukocytes, progenitor cells (Gastrointestinal progenitor stem cells, GIP-C).

Thermo Fisher Scientific, today announced that it has developed a comprehensive method for the identification, confirmation and quantitation of illicit drugs and their salt forms.

Dominion Diagnostics now offers UPLC/MS/MS testing for metabolites of synthetic marijuana compounds JWH-018 and JWH-073.

The GNR Traffic Light is the latest addition to AdvanDx's molecular-based PNA FISH diagnostics platform designed to provide therapy-guiding results.

New Core Panel designed to help researchers study genetic predispositions for differential drug response and adverse events.

ERT, a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced the launch of Centralized Cardiac Safety 2.0, a portfolio of new solutions that enable a significant new approach to cardiac safety in clinical trials.

The set-up delivers laboratory analysis, data management and project monitoring to support global clinical trials.